Tecelra is the first engineered cell therapy for the treatment of certain patients with advanced synovial sarcoma. One year after approval, there are still questions about why it seems to work better in some patients.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/treating-tecelra-post-approval-what-have-docs-learned-2025a1000wwo?src=rss
Author :
Publish date : 2025-11-25 11:05:00
Copyright for syndicated content belongs to the linked Source.
